FIELD: chemistry.
SUBSTANCE: invention refers to a compound of formula 1, where R2 represents hydrogen or dimethylaminogroup; R3 represents hydrogen; R4 represents C3-10-cycloalkyl optionally substituted by C1-6-alkyl, or benzyl optionally substituted by halogen; or R3 and R4 together with nitrogen atom, to which they are attached, form piperidinyl substituted by one or more substitutes independently specified in a group consisting of hydroxyl or phenyl optionally substituted by halogen; R5 represents C1-6-alkyl or benzyl optionally substituted by halogen; R6 represents benzodioxolyl or phenyl optionally substituted by 1-3 substitutes independently specified in a group consisting of halogen, hydroxyl, C1-6-alkoxygroup optionally substituted by halogen, C1-6-alkyl, phenoxygroup optionally substituted by halogen, cyanogroup or C1-6-alkyl, and phenyl optionally substituted by C1-6-alkyl or halogen, or its pharmaceutically acceptable salt. The compound of formula 1 is applicable for producing a composition or a medicinal product for treating or controlling cell proliferative disorders.
EFFECT: sultam derivatives showing cytotoxic activity.
40 cl, 38 ex
Title | Year | Author | Number |
---|---|---|---|
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
DERIVATIVES OF BENZOTHIAZINE DIOXIDE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF SHOWING INHIBITORY ACTIVITY OF ENDOTHELIN RECEPTOR AND METHOD OF INHIBITION OF ENDOTHELIN RECEPTOR | 1996 |
|
RU2164225C2 |
GLUTATHIONE-AMMONIUM SALTS OF O,O-DIORGANYL DITHIOPHOSPHORIC ACIDS, HAVING ANTIOXIDANT AND ANTICANCER ACTIVITY | 2018 |
|
RU2692065C1 |
PYRAZOLES | 2006 |
|
RU2381217C2 |
CHIRAL MONOTERPENE SULFINAMIDES | 2017 |
|
RU2646959C1 |
METHOD FOR PREPARATION OF CHIRAL MONOTERPENE SULFINAMIDES | 2017 |
|
RU2650681C1 |
SUBSTITUTED PYRROLIDIN-2-CARBOXAMIDE | 2011 |
|
RU2564022C2 |
TLR7 AGONISTS | 2019 |
|
RU2817014C2 |
RENNIN INHIBITOR SYNTHESIS WITH USING CYCLOADDITION REACTION | 2006 |
|
RU2423348C2 |
Authors
Dates
2015-10-20—Published
2010-11-19—Filed